Milestone Pharmaceuticals (MIST) Research & Development (2018 - 2022)
Milestone Pharmaceuticals (MIST) posted Research & Development of $9.8 million for Q3 2022, down 7.8% on a QoQ basis from $10.7 million in Q2 2022, and up 0.96% year-over-year from $9.7 million in Q3 2021.
Milestone Pharmaceuticals (MIST) Research & Development (2018 - 2022) Analysis & Trends
Milestone Pharmaceuticals' Research & Development history runs 5 years deep, the most recent figure standing at $9.8 million for Q3 2022.
- Quarterly Research & Development rose 0.96% year-over-year to $9.8 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $41.1 million (up 22.71% YoY) and the FY2021 annual result came in at $38.7 million, up 12.13% from the prior year.
- Research & Development was $9.8 million for Q3 2022 at Milestone Pharmaceuticals, down from $10.7 million in the prior quarter.
- Across five years, Research & Development topped out at $14.1 million in Q4 2019 and bottomed at $2.6 million in Q2 2018.
- A 5-year average of $8.5 million and a median of $9.0 million in 2020 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2019 — Research & Development soared 312.66% — and 2020, when it tumbled 59.25%.
- Milestone Pharmaceuticals' Research & Development stood at $7.3 million in 2018, then surged by 93.9% to $14.1 million in 2019, then tumbled by 59.25% to $5.8 million in 2020, then surged by 89.32% to $10.9 million in 2021, then retreated by 9.99% to $9.8 million in 2022.
- Business Quant data shows MIST's Research & Development at $9.8 million in Q3 2022, $10.7 million in Q2 2022, and $10.9 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 9.83 Mn |
| Jun 30, 2022 | 10.66 Mn |
| Dec 31, 2021 | 10.92 Mn |
| Sep 30, 2021 | 9.73 Mn |
| Jun 30, 2021 | 9.43 Mn |
| Mar 31, 2021 | 8.60 Mn |
| Dec 31, 2020 | 5.77 Mn |
| Sep 30, 2020 | 8.23 Mn |
| Jun 30, 2020 | 8.62 Mn |
| Mar 31, 2020 | 11.87 Mn |
| Dec 31, 2019 | 14.15 Mn |
| Sep 30, 2019 | 9.55 Mn |
| Jun 30, 2019 | 10.53 Mn |
| Mar 31, 2019 | 7.77 Mn |
| Dec 31, 2018 | 7.30 Mn |
| Sep 30, 2018 | 3.91 Mn |
| Jun 30, 2018 | 2.55 Mn |
| Mar 31, 2018 | 3.09 Mn |